SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001044321-06-000234
Filing Date
2006-04-24
Accepted
2006-04-24 12:57:16
Documents
1
Group Members
AUSTIN W. MARXEAWM INVESTMENT COMPANY, INC.DAVID M. GREENHOUSELS ADVISERS, LLCMG ADVISERS, L.L.C.MGP ADVISERS LIMITED PARTNERSHIPSPECIAL SITUATIONS CAYMAN FUND, L.P.SPECIAL SITUATIONS FUND III QP, L.P.SPECIAL SITUATIONS FUND III, L.P.SPECIAL SITUATIONS LI

Document Format Files

Seq Description Document Type Size
1 pharmafrontiers13dt.txt SC 13D 9711
  Complete submission text file 0001044321-06-000234.txt   12345
Mailing Address C/O SPECIAL SITUATIONS FUNDS 527 MADISON AVENUE, SUITE 2600 NEW YORK NY 10022
Business Address C/O SPECIAL SITUATIONS FUNDS 527 MADISON AVENUE, SUITE 2600 NEW YORK NY 10022 2122076500
MARXE AUSTIN W & GREENHOUSE DAVID M (Filed by) CIK: 0001044321 (see all company filings)

IRS No.: 000000000
Type: SC 13D

Mailing Address 2635 N. CRESCENT RIDGE DRIVE THE WOODLANDS TX 77381
Business Address 2635 N. CRESCENT RIDGE DRIVE THE WOODLANDS TX 77381 (281) 272-9331
PharmaFrontiers Corp. (Subject) CIK: 0001069308 (see all company filings)

IRS No.: 760333165 | State of Incorp.: TX | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-81104 | Film No.: 06774604
SIC: 2834 Pharmaceutical Preparations